Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xinglou Chengqi Granule for Acute Ischemic Stroke (EXACT)
NCT07163702Phase 2Not yet recruiting
- Sponsor
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
- Start
- Oct 2025
- Primary completion
- Sep 2026
- Modality
- Botanical drug combination
- Countries
- 1
01
Overview
A Phase 2 trial of Xinglou Chengqi Decoction in ischemic stroke, sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
Xinglou Chengqi Decoction
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07163702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07163702.